- Příznivé výsledky klinických studií fáze III s tirzepatidem2022 | First Faculty of Medicine
- Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: the Tarceva Lung Cancer Investigation Trial2007 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial2010 | First Faculty of Medicine
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.2011 | First Faculty of Medicine
- Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial2009 | First Faculty of Medicine
- An assessment of adalimumab efficacy in three Phase III clinical trials using the European Consensus Programme criteria for psoriasis treatment goals2013 | Faculty of Medicine in Pilsen
- Sklopísek Střeleč, assessment of stability inside the hopper, Phase III: Numerical Analysis, plus dumpPublication without faculty affiliation
- Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia2012 | First Faculty of Medicine
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial.2010 | First Faculty of Medicine
- Sustained long-term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double-blind, phase III study2020 | Faculty of Medicine in Pilsen
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study2009 | Publication without faculty affiliation
- Efficacy and safety of risankizumab vs. secukinumab in patients with moderate-to-severe plaque psoriasis (IMMerge): results from a phase III, randomized, open-label, efficacy-assessor-blinded clinical trial2020 | Faculty of Medicine in Pilsen
- Results of the CONFIRM phase IIItrial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor–positive advanced breast cancer2010 | First Faculty of Medicine
- Intestinal permeability, vitamin A absorption and serum alpha-tocopherol during therapy with gefitinib2010 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Comment to study: A randomized phase |III study of FOLFIRI plus cetuximab or bevacizumab as first-line treatment for wild type (WT) KRAS metastatic colorectal cancer (mCRC) patients: German study AIO KRK-0306(FIRE-3)2013 | First Faculty of Medicine
- Current therapeutic options in fibriomyalgia.2009 | First Faculty of Medicine
- Research Report University Hospital for clinical assessment M12-555Publication without faculty affiliation
- Research Report University Hospital for clinical evaluation of BAY 73-4506/15982Publication without faculty affiliation
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. CA204004Publication without faculty affiliation
- Research Report University Hospital for clinical assessment OMB113676Publication without faculty affiliation
- Research Report University Hospital of the clinical trial APL-C-001-09Publication without faculty affiliation
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. CSL627_3001Publication without faculty affiliation
- Kazuistika s dlouhodobou léčebnou odpovědí na terapii axitinibem2019 | First Faculty of Medicine
- Finding an economical solution to eradicate cervical cancer. Comment on the article: "How to effectively eradicate cervical cancer2004 | Publication without faculty affiliation
- Research Report University Hospital for clinical assessment CAIN457A2304E1Publication without faculty affiliation
- Research Report University Hospital for clinical assessment TPU-TAS-102-301Publication without faculty affiliation
- Report of University Hospital Hradec Králové to the clinical trial protocol No: APL-C-001-09Publication without faculty affiliation
- Research Report University Hospital clinical trial 20120229Publication without faculty affiliation
- Research Report University Hospital for clinical assessment BAY 86-5321 / 91745Publication without faculty affiliation
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. GO28667Publication without faculty affiliation